Andrea Nozza

1.7k total citations
44 papers, 859 citations indexed

About

Andrea Nozza is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Andrea Nozza has authored 44 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 19 papers in Oncology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Andrea Nozza's work include Multiple Myeloma Research and Treatments (19 papers), Peripheral Neuropathies and Disorders (10 papers) and Cancer Treatment and Pharmacology (9 papers). Andrea Nozza is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Peripheral Neuropathies and Disorders (10 papers) and Cancer Treatment and Pharmacology (9 papers). Andrea Nozza collaborates with scholars based in Italy, Germany and United States. Andrea Nozza's co-authors include Armando Santoro, Monica Balzarotti, Luca Castagna, Licia Siracusano, Eduardo Nobile‐Orazio, Massimo Magagnoli, Barbara Sarina, Fabrizia Terenghi, Francesca Gallia and Michele Spina and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Andrea Nozza

42 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Nozza Italy 18 352 345 315 294 183 44 859
Jean Pierre Marolleau France 17 324 0.9× 397 1.2× 263 0.8× 79 0.3× 198 1.1× 53 977
Mars van’t Veer Netherlands 7 302 0.9× 586 1.7× 221 0.7× 409 1.4× 71 0.4× 8 1.0k
Ali Mazloom United States 16 305 0.9× 323 0.9× 127 0.4× 282 1.0× 112 0.6× 32 788
Wolf‐Dieter Ludwig Germany 15 276 0.8× 424 1.2× 481 1.5× 142 0.5× 232 1.3× 25 1.0k
Qin Huang United States 16 238 0.7× 245 0.7× 398 1.3× 70 0.2× 220 1.2× 62 887
M. J. Lacombe France 14 203 0.6× 180 0.5× 105 0.3× 91 0.3× 98 0.5× 22 964
Sarah M. Larson United States 14 343 1.0× 201 0.6× 262 0.8× 82 0.3× 180 1.0× 74 749
Chikako Ohwada Japan 16 122 0.3× 87 0.3× 359 1.1× 147 0.5× 104 0.6× 63 691
Hirotaka Takasaki Japan 16 244 0.7× 317 0.9× 153 0.5× 111 0.4× 80 0.4× 59 732
Elif Yakisan Germany 11 254 0.7× 391 1.1× 146 0.5× 176 0.6× 93 0.5× 12 747

Countries citing papers authored by Andrea Nozza

Since Specialization
Citations

This map shows the geographic impact of Andrea Nozza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Nozza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Nozza more than expected).

Fields of papers citing papers by Andrea Nozza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Nozza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Nozza. The network helps show where Andrea Nozza may publish in the future.

Co-authorship network of co-authors of Andrea Nozza

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Nozza. A scholar is included among the top collaborators of Andrea Nozza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Nozza. Andrea Nozza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gentile, Francesco, Fabrizia Terenghi, Pietro Emiliano Doneddu, et al.. (2023). Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome. Neurological Sciences. 45(2). 727–733.
2.
Montefusco, Vittorio, Alessandro Corso, Mónica Galli, et al.. (2020). Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse. British Journal of Haematology. 188(6). 907–917. 7 indexed citations
3.
Autore, Francesco, Nicola Piccirillo, Andrea Nozza, et al.. (2019). Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers. Biology of Blood and Marrow Transplantation. 25(12). 2514–2516. 4 indexed citations
4.
Bonfichi, Maurizio, Simone Ferrero, Giacomo Malipiero, et al.. (2018). Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program. Hematological Oncology. 36(4). 689–692. 6 indexed citations
5.
Bianco, Mariangela, Fabrizia Terenghi, Francesca Gallia, et al.. (2018). Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome. Journal of Neurology Neurosurgery & Psychiatry. 90(3). 367–368. 4 indexed citations
6.
Nozza, Andrea, Fabrizia Terenghi, Francesca Gallia, et al.. (2017). Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open‐label trial. British Journal of Haematology. 179(5). 748–755. 51 indexed citations
7.
Patriarca, Francesca, Benedetto Bruno, Hermann Einsele, et al.. (2017). Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation. Biology of Blood and Marrow Transplantation. 24(2). 406–409. 18 indexed citations
8.
Nobile‐Orazio, Eduardo, Mariangela Bianco, & Andrea Nozza. (2017). Advances in the Treatment of Paraproteinemic Neuropathy. Current Treatment Options in Neurology. 19(12). 43–43. 29 indexed citations
9.
Patriarca, Francesca, Hermann Einsele, Francesco Spina, et al.. (2011). Allogeneic Stem Cell Transplantation in Multiple Myeloma Relapsed after Autograft: A Multicenter Retrospective Study Based on Donor Availability. Biology of Blood and Marrow Transplantation. 18(4). 617–626. 54 indexed citations
10.
Corso, Alessandro, Mónica Galli, Silvia Mangiacavalli, et al.. (2011). Response‐adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression‐free survival in transplanted patients with multiple myeloma. American Journal of Hematology. 87(2). 150–154. 8 indexed citations
11.
Tancioni, Flavio, Pierina Navarria, Andrea Nozza, et al.. (2010). Vertebroplasty for pain relief and spinal stabilization in multiple myeloma. Neurological Sciences. 31(2). 151–157. 20 indexed citations
12.
Castagna, Luca, Stéfania Bramanti, Monica Balzarotti, et al.. (2009). Predictive value of early 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high‐dose chemotherapy. British Journal of Haematology. 145(3). 369–372. 38 indexed citations
13.
Todisco, Elisabetta, Luca Castagna, Barbara Sarina, et al.. (2007). CD34+ dose‐driven administration of granulocyte colony‐stimulating factor after high‐dose chemotherapy in lymphoma patients. European Journal Of Haematology. 78(2). 111–116. 4 indexed citations
14.
Castagna, Luca, Massimo Magagnoli, Monica Balzarotti, et al.. (2006). Tandem high‐dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study. American Journal of Hematology. 82(2). 122–127. 22 indexed citations
15.
Nozza, Andrea, Luca Castagna, Daoud Rahal, Massimo Magagnoli, & Armando Santoro. (2003). Massive liver involvement in a patient with multiple myeloma during thalidomide treatment. Frontiers in Physiology. 6(2). 230–232. 4 indexed citations
16.
Bertuzzi, Alexia, Luca Castagna, Vittorio Quagliuolo, et al.. (2003). Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumour. British Journal of Cancer. 89(7). 1159–1161. 22 indexed citations
17.
Magagnoli, Massimo, Luca Castagna, Monica Balzarotti, et al.. (2003). Feasibility and toxicity of high‐dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non‐Hodgkin's lymphoma: Survey from a single institution. American Journal of Hematology. 73(4). 267–272. 11 indexed citations
18.
Balzarotti, Monica, Michele Spina, Barbara Sarina, et al.. (2002). Intensified CHOP regimen in aggressive lymphomas:maximal dose intensity and dose density of doxorubicin and cyclophosphamide. Annals of Oncology. 13(9). 1341–1346. 23 indexed citations
19.
Castagna, Luca, Alexia Bertuzzi, Andrea Nozza, et al.. (2002). Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas. Bone Marrow Transplantation. 30(4). 207–214. 8 indexed citations
20.
Magagnoli, Massimo, Barbara Sarina, Monica Balzarotti, et al.. (2001). Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma. Bone Marrow Transplantation. 28(10). 923–927. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026